Latest News

Bonti launches Phase II trial of EB-001 for musculoskeletal pain

US-based biotechnology firm Bonti has launched a Phase II clinical trial (LANTERN-1) of EB-001 to treat patients with musculoskeletal...

Bonti launches Phase II trial of EB-001 for musculoskeletal pain

Cancer Research UK begins new trial for advanced cancer drug

Cancer Research UK begins new trial for advanced cancer drug

Zealand partner Boehringer begins Phase I trials for two obesity and/or diabetes drugs

Zealand Pharma has announced the launch of two Phase I clinical trials by its partner Boehringer Ingelheim to investigate a glucagon / GLP-1 agonist and an amylin analogue for the treatment...

Zealand partner Boehringer begins Phase I trials for two obesity and/or diabetes drugs

Astellas starts dosing gilteritinib patients in Phase III trial to treat AML

Astellas starts dosing gilteritinib patients in Phase III trial to treat AML

Pfizer and AFT initiate Phase III trial of HER2+ breast cancer drug

Pfizer and the Alliance Foundation Trials have partnered with six international cancer research groups to initiate a Phase III clinical trial (PATINA) of palbociclib (IBRANCE) in patients...

Pfizer and AFT initiate Phase III trial of HER2+ breast cancer drug

Ovid begins randomisation in Phase Ib/IIa trial of epilepsy drug

Ovid Therapeutics has begun patient randomisation in a Phase Ib/IIa clinical trial of TAK-935 (OV935) to treat adults with rare...

Ovid begins randomisation in Phase Ib/IIa trial of epilepsy drug

Novartis and MMV initiate Phase IIb trial of KAF156 for malaria in Africa

Novartis and Medicines for Malaria Venture (MMV) have initiated a Phase IIb clinical trial of KAF156 to treat multidrug-resistant malaria in...

Novartis and MMV initiate Phase IIb trial of KAF156 for malaria in Africa

Bod Australia concludes Phase I trial design for cannabis extract

Natural medicines developer Bod Australia has concluded the design for a Phase I clinical trial of its pharmaceutical grade cannabis extract in combination with a new delivery...

Bod Australia concludes Phase I trial design for cannabis extract

MatriSys commences dosing in Phase IIa trial for atopic dermatitis

MatriSys commences dosing in Phase IIa trial for atopic dermatitis

Imatinib shows increased survival in ICR’s Phase III oncology trial

Imatinib shows increased survival in ICR’s Phase III oncology trial

Medivir enrols first patient in combination trial for refractory solid tumours

Swedish pharmaceutical company Medivir has started patient enrolment in a Phase I/II clinical trial of its product candidate birinapant in combination with Merck’s anti-PD-1 therapy...

Medivir enrols first patient in combination trial for refractory solid tumours

Cellectis starts dosing patients in UCART123’s Phase I trial for BPDCN

Biopharmaceutical firm Cellectis has started dosing patients in a Phase I clinical trial of its universal chimeric antigen receptor T-cell (UCART) product candidate UCART123 to treat...

Cellectis starts dosing patients in UCART123’s Phase I trial for BPDCN

Amgen’s EBBINGHAUS trial of Repatha shows favourable outcome

Amgen’s EBBINGHAUS trial of Repatha shows favourable outcome

Deals this week: NicOx, FibroGen, Omeros

NicOx has announced the private placement of 3.5 million new ordinary shares priced at €7.5 ($8.85) each to raise €26.25m ($30.97m) in...

Deals this week: NicOx, FibroGen, Omeros

TRACON Pharmaceuticals reports positive results from Phase Ib/II trial of HCC drug

TRACON Pharmaceuticals has reported positive results from the National Cancer Institute (NCI) Phase Ib/II clinical trial of TRC105 and Nexavar (sorafenib) to treat patients with...

TRACON Pharmaceuticals reports positive results from Phase Ib/II trial of HCC drug

M&As this week: Evotec, BioreclamationIVT

German pharmaceutical research company Evotec has acquired US-based drug discovery and development company Aptuit for...

M&As this week: Evotec, BioreclamationIVT

Lexicon announces additional positive Phase III data for diabetes drug

Lexicon Pharmaceuticals has reported additional positive data from its Phase III inTandem2 clinical trial of sotagliflozin in adult type 1 diabetes patients on a background of optimised insulin. ...

Lexicon announces additional positive Phase III data for diabetes drug

Iovance commences LN-145 dosing in Phase II trial for cervical cancer

Iovance commences LN-145 dosing in Phase II trial for cervical cancer

Achieve begins cytisine’s clinical programme for smoking cessation

Achieve Life Sciences has initiated the Cytisine Clinical Development Programme in the US to evaluate the product candidate as a form of treatment for smoking...

Achieve begins cytisine’s clinical programme for smoking cessation

Vyriad and Sanford Health begin Phase I viro-immunotherapy trial

US-based biopharmaceutical firm Vyriad has initiated a clinical trial at integrated health system Sanford Health to evaluate a genetically engineered virus for destroying therapy-resistant tumours. ...

Vyriad and Sanford Health begin Phase I viro-immunotherapy trial

BMS Phase III’s combination trial for RCC meets one co-primary endpoint

Bristol-Myers Squibb (BMS) has reported top-line results from the Phase III CheckMate -214 clinical trial of Opdivo (nivolumab) and Yervoy (ipilimumab) combination to treat advanced or...

BMS Phase III’s combination trial for RCC meets one co-primary endpoint